Fierce

HeartFlow Announces Publication of 10-year Follow-Up Data from the DISCOVER-FLOW Study in the Journal of Cardiovascular Computed Tomography

Retrieved on: 
Tuesday, March 12, 2024
Diagnosis, FACC, Coronary artery disease, Risk, Patient, Atherosclerosis, CTA, Journal, Artificial intelligence, FFR, AI, Fierce, Safety, Trailblazer, CAD, Medical device

MOUNTAIN VIEW, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced that 10-year follow-up data from its DISCOVER-FLOW study were published in the Journal of Cardiovascular Computed Tomography.

Key Points: 
  • MOUNTAIN VIEW, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced that 10-year follow-up data from its DISCOVER-FLOW study were published in the Journal of Cardiovascular Computed Tomography .
  • The company has spent the last decade working with clinicians to improve CAD diagnosis, making significant progress validated by high quality clinical evidence.
  • HeartFlow’s approach is centered around scientific rigor with peer-reviewed publications to provide confidence and certainty to clinicians and the patients they serve.
  • Together, this comprehensive solution offers valuable data not currently available with other non-invasive diagnostic tools or CTA-based AI analyses.

Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development

Retrieved on: 
Monday, April 1, 2024
Health, Stem Cells, Genetics, General Health, Research, Science, Biotechnology, Stem cell, B cell, Regenerative medicine, Agriculture, Global health, Lineage, Madrona Venture Group, Duke University, Beckman Research Institute, City, Columbia University, University, NanoString Technologies, Fierce, Doctor of Philosophy, Investment, Therapy, Microbiology, Partner, Corporate development, Pharmaceutical industry

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the appointment of veteran industry executive Charlotte Hubbert, Ph.D., as Vice President of Corporate Development.

Key Points: 
  • Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced the appointment of veteran industry executive Charlotte Hubbert, Ph.D., as Vice President of Corporate Development.
  • Most recently, Dr. Hubbert served in the leadership team at NanoString Technologies .
  • “We are excited to add such a talented executive to our management team in the newly created position of VP Corporate Development.
  • Dr. Hubbert’s decades of experience in cell therapy, strategic investment, and partnering make her a valuable and welcome addition to the Lineage team,” stated Brian M. Culley, CEO.

Noah Medical Named a “Fierce 15” Company of 2023 by Fierce MedTech

Retrieved on: 
Wednesday, March 6, 2024
SAN, Fierce, Physician, Growth, Silicon, Fluoroscopy, Medtech, Patient, Lung cancer, Galaxy, Diagnosis, Noah, Medical device

SAN CARLOS, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical announced today that Fierce MedTech has named it one of 2023’s “Fierce 15” medical technology companies.

Key Points: 
  • SAN CARLOS, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical announced today that Fierce MedTech has named it one of 2023’s “Fierce 15” medical technology companies.
  • “Winning the Fierce 15 award is a shared triumph for both our exceptional team at Noah and the customers who’ve played an instrumental role in making Galaxy a leader in minimally invasive early lung cancer diagnosis,” said Noah Medical CEO Jian Zhang.
  • The Galaxy System was also recently recognized as a Medtech Breakthrough winner and named a finalist in the 2023 Fierce Innovation Awards: Life Sciences Edition.
  • “These companies exemplify the ability of the MedTech industry to turn cutting-edge ideas into meaningful outcomes and make them accessible on a large scale.”
    To learn more about Noah Medical and the Galaxy System, please visit noahmed.com .

Increased Venture Capital Investment Bolsters Women's Health Startups

Retrieved on: 
Monday, January 8, 2024
Annual report, Pregnancy, Women's health, Health care, Woman, First Citizens BancShares, Research, Public, FDA, Menopause, Health, SAN, Fertility, Mental health, Fierce, Silicon Valley Bank, Initial public offering, Data collection, Therapy, SVB, Environment, Pharmaceutical industry

SAN FRANCISCO, Jan. 8, 2024 /PRNewswire/ -- Despite ongoing economic headwinds and a pressured venture fundraising environment, investment in startup companies addressing women's health is on the rise. According to a recent report from Silicon Valley Bank (SVB), a division of First Citizens Bank, investment in women's health companies increased 314% since 2018, while overall investment for the health sector increased 28%.

Key Points: 
  • According to a recent report from Silicon Valley Bank (SVB), a division of First Citizens Bank, investment in women's health companies increased 314% since 2018, while overall investment for the health sector increased 28%.
  • SVB's Innovation in Women's Health Report examines fundraising and investment activity as well as capital and valuation trends across the sector.
  • The report defines women's health as healthtech, biopharma, diagnostics/tools, and medical device companies that address underserved care needs for women.
  • "Despite broader challenges in the larger venture capital landscape, women's health is showing significant momentum and progress," said Raysa Bousleiman, co-author of the SVB Innovation in Women's Health report and VP of Venture Capital Relationship Management for Life Science and Healthcare at SVB.

BrightInsight Ranked 307th Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500

Retrieved on: 
Wednesday, November 29, 2023
Marketing, EHR, Entrepreneurship, Food, Fintech, Software, Telecommunications, Medicine, Medical device, Health (Apple), San Francisco Bay Area, Medtech, MD, SAN, Internet of things, Fierce, FHIR, Ophthalmology, Engineering, NFC, Electronic health record, Growth, Diagnosis, Platform, Population Health Management, LIS, 307th

SAN JOSE, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- BrightInsight, Inc. , provider of the leading global platform for biopharma and medtech compliant digital health solutions, today announced it ranked 307th on the Deloitte Technology Fast 500 ™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America.

Key Points: 
  • SAN JOSE, Calif., Nov. 29, 2023 (GLOBE NEWSWIRE) -- BrightInsight, Inc. , provider of the leading global platform for biopharma and medtech compliant digital health solutions, today announced it ranked 307th on the Deloitte Technology Fast 500 ™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America.
  • BrightInsight grew 431% between 2019 and 2022 and ranked 56th of the 94 Fast 500 companies based in the Bay Area, and 174th of the 310 software and services companies.
  • “We are honored to be recognized again as one of the fastest growing companies in North America.
  • Frost & Sullivan named BrightInsight the 2023 Frost & Sullivan Global Company of the Year in the IoT healthcare solutions industry.

On/Go Named 2023 Fierce 50 Social Impact Honoree For Its Charitable Work Via On/Go for Good

Retrieved on: 
Friday, October 6, 2023
Health, COVID-19, Hospital, Make-A-Wish Foundation, American Diabetes Association, Fierce, Organization, Population health, COVID-19 testing, Entrepreneurship, Mental health, Good, Education, The Co Founder, Software, GO Campaign, Social impact, Computer, Nursing, San Francisco Bay Area

Fierce 50 recognizes individuals and organizations that confront pressing health challenges, fostering awareness and education while implementing interventions that have a profound impact on the fabric of health and well-being.

Key Points: 
  • Fierce 50 recognizes individuals and organizations that confront pressing health challenges, fostering awareness and education while implementing interventions that have a profound impact on the fabric of health and well-being.
  • The group of 50 has been honored for leading the charge on crucial social issues.
  • The approach of "doing good by doing well" has benefitted hundreds of millions of people globally.
  • When good people are sometimes unsure and hesitant about how to make a difference - we're inclined to a rapid action-learning-iterations cycle that results in real impact.

Fierce Names GHLF’s Daniel Hernandez, MD, Among Its Fierce 50 Honorees

Retrieved on: 
Wednesday, October 4, 2023
Biotechnology, Pharmaceutical, Managed Care, General Health, Health, Hispanic, Consumer, Other Health, WhatsApp, Medical Affairs Bureau, Health care, Multimedia, Research, Health Resources and Services Administration, Fierce, Patient, Physician, Edison Theatre, Growth, Rheumatoid arthritis, Nursing, MD

The Global Healthy Living Foundation (GHLF) is pleased to announce that Daniel Hernandez, MD, GHLF’s Director of Medical Affairs and Hispanic Outreach, has been recognized as a 2023 Fierce 50 honoree by Fierce Healthcare and Fierce Life Sciences.

Key Points: 
  • The Global Healthy Living Foundation (GHLF) is pleased to announce that Daniel Hernandez, MD, GHLF’s Director of Medical Affairs and Hispanic Outreach, has been recognized as a 2023 Fierce 50 honoree by Fierce Healthcare and Fierce Life Sciences.
  • The Fierce 50 showcases 50 companies and individuals making a significant impact and driving progress in the pharmaceutical, health care, and biotech industries.
  • At GHLF, Dr. Hernandez not only guides a team of consulting physicians but also leads Hispanic outreach initiatives.
  • More details are available at https://fierce50.fiercelifesciences.com/ , and the full Fierce 50 list can be accessed at www.fiercepharma.com/fierce-50 .

Fierce Names Dr. Dennis Wall, Founder of Cognoa, as One of its Fierce 50 Honorees of 2023

Retrieved on: 
Tuesday, October 3, 2023
Learning, Drug development, University, Health, PALO, Health care, Department of Neurobiology, Harvard Medical School, Intelligence, Medicine, Research, Doctor of Philosophy, Genetics, Computation, Fierce, Physician, Edison Theatre, Child, University of California, Berkeley, Spectrum, Genome, Growth, FDA, Family, Pharmaceutical industry, Nursing, Stanford University

PALO ALTO, Calif., Oct. 3, 2023 /PRNewswire/ -- Cognoa , the leading child health company, today announced that Fierce Healthcare and Fierce Life Sciences have named the company's Founder, Dr. Dennis Wall, as one of 2023's Fierce 50 honorees.

Key Points: 
  • PALO ALTO, Calif., Oct. 3, 2023 /PRNewswire/ -- Cognoa , the leading child health company, today announced that Fierce Healthcare and Fierce Life Sciences have named the company's Founder, Dr. Dennis Wall, as one of 2023's Fierce 50 honorees.
  • The Fierce 50 showcases 50 companies and individuals driving advancements in medicine, fostering innovation, and shaping the future of biopharma and healthcare.
  • The Fierce 50 is a constellation of the most brilliant visionaries and trailblazers, handpicked by the discerning editors of Fierce Biotech, Fierce Pharma and Fierce Healthcare.
  • The Fierce 50 honorees will be celebrated live at an evening gala at the Edison Ballroom in New York on December 5th.

Fierce Names Dr. Dennis Wall, Founder of Cognoa, as One of its Fierce 50 Honorees of 2023

Retrieved on: 
Tuesday, October 3, 2023
Learning, Drug development, University, Health, PALO, Health care, Department of Neurobiology, Harvard Medical School, Intelligence, Medicine, Research, Doctor of Philosophy, Genetics, Computation, Fierce, Physician, Edison Theatre, Child, University of California, Berkeley, Spectrum, Genome, Growth, FDA, Family, Pharmaceutical industry, Nursing, Stanford University

PALO ALTO, Calif., Oct. 3, 2023 /PRNewswire/ -- Cognoa , the leading child health company, today announced that Fierce Healthcare and Fierce Life Sciences have named the company's Founder, Dr. Dennis Wall, as one of 2023's Fierce 50 honorees.

Key Points: 
  • PALO ALTO, Calif., Oct. 3, 2023 /PRNewswire/ -- Cognoa , the leading child health company, today announced that Fierce Healthcare and Fierce Life Sciences have named the company's Founder, Dr. Dennis Wall, as one of 2023's Fierce 50 honorees.
  • The Fierce 50 showcases 50 companies and individuals driving advancements in medicine, fostering innovation, and shaping the future of biopharma and healthcare.
  • The Fierce 50 is a constellation of the most brilliant visionaries and trailblazers, handpicked by the discerning editors of Fierce Biotech, Fierce Pharma and Fierce Healthcare.
  • The Fierce 50 honorees will be celebrated live at an evening gala at the Edison Ballroom in New York on December 5th.

Fierce names Pat Garcia-Gonzalez, Founder and CEO of The Max Foundation as one of its Fierce 50 Honorees of 2023 in the Health Equity Category

Retrieved on: 
Monday, October 2, 2023
Partnership, Drug development, Health, CML, Health care, Health equity, Cancer, Medicine, Research, Acute leukemia, Hospital, Fierce, Non-governmental organization, Patient, Physician, Edison Theatre, Entrepreneurship, Disease, Pharmaceutical industry

The Fierce 50 showcases 50 companies and individuals driving advancements in medicine, fostering innovation, and shaping the future of biopharma and healthcare.

Key Points: 
  • The Fierce 50 showcases 50 companies and individuals driving advancements in medicine, fostering innovation, and shaping the future of biopharma and healthcare.
  • "These outstanding individuals and companies exemplify excellence in their fields, and their dedication to innovation and improving lives is truly commendable.
  • The Fierce 50 is a constellation of the most brilliant visionaries and trailblazers, handpicked by the discerning editors of Fierce Biotech, Fierce Pharma and Fierce Healthcare.
  • The Fierce 50 honorees will be celebrated live at an evening gala at the Edison Ballroom in New York on December 5th.